Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Cord vs. haplo in SAA

Rainer Storb • 26 Oct 2019
COSTEM 2019
Anemias Aplastic Anemia

Rainer Storb, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, outlines the differences between cord and haploidentical donor sources in SAA and also evaluates the efficacy of haploidentical as a preferred donor source to cord in severe aplastic anemia (SAA). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Rainer Storb

1:58
ASCT in the outpatient setting
Rainer Storb • 28 Oct 2019
0:55
Total body irradiation vs. chemotherapy-based myeloablative conditioning for ASCT
Rainer Storb • 26 Oct 2019

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A 2-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
1:31
Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency
Hanny Al-Samkari • 9 Dec 2023
2:13
SATISFY: mitapivat in patients with erythrocyte membranopathies
Kevin Kuo • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals